|
|
Recent news from the US Food and Drug Administration.
Click title to see the full article at the FDA
website. For the most up-to-date headlines, check out the FDA
Newsroom. Press announcements from 2004 to 2009 are available through
the FDA
Archive.
FDA
Recalls: FDA posts press releases and other notices of recalls and
market withdrawals from the firms involved as a service to consumers,
the media, and other interested parties. FDA does not endorse either the
product or the company. This site does not contain a complete list of
recalls -
search for recalls at the official FDA site.
| November 15, 2024 - FDA
Roundup: November 15, 2024 |
| November 14, 2024 - FDA
Approves First Gene Therapy for Treatment of Aromatic L-amino Acid
Decarboxylase Deficiency |
| November 8, 2024 - FDA
Roundup: November 8, 2024 |
| November 7, 2024 - FDA
Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant
Active Ingredient After Extensive Review |
| November 5, 2024 - FDA
Roundup: November 5, 2024 |
| November 1, 2024 - FDA
Roundup: November 1, 2024 |
| October 29, 2024 - FDA
Roundup: October 29, 2024 |
| October 25, 2024 - FDA
Roundup: October 25, 2024 |
| October 22, 2024 - $76
Million in Illegal E-Cigarettes Seized in Joint Federal Operation |
| October 18, 2024 - FDA
Roundup: October 18, 2024 |
| October 15, 2024 - FDA
Roundup: October 15, 2024 |
| October 11, 2024 - FDA
Roundup: October 11, 2024 |
| October 11, 2024 - FDA
Approves New Treatment for Hemophilia A or B |
| October 8, 2024 - Federal
Court Enters Consent Decree Against Rizo Lopez Foods Inc. Following
Multistate Outbreak of Listeriosis Linked to Queso Fresco and Cotija
Cheese Products |
| October 7, 2024 - FDA
Authorizes Marketing of First Home Flu and COVID-19 Combination Test
Outside of Emergency Use Authorities |
| October 4, 2024 - FDA
Roundup: October 4, 2024 |
| October 1, 2024 - FDA’s
Unified Human Foods Program, New Model for Field Operations, and Other
Modernization Efforts Go into Effect |
| October 1, 2024 - FDA
Roundup: October 1, 2024 |
| September 27, 2024 - FDA
Roundup: September 27, 2024 |
| September 26, 2024 - FDA
Approves Drug with New Mechanism of Action for Treatment of Schizophrenia |
| September 24, 2024 - FDA
Approves New Drug to Treat Niemann-Pick Disease, Type C |
| September 24, 2024 - FDA
Roundup: September 24, 2024 |
| September 20, 2024 - FDA
Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration |
| September 20, 2024 - FDA
Approves First Treatment for Niemann-Pick Disease, Type C |
| September 20, 2024 - FDA
Roundup: September 20, 2024 |
| September 17, 2024 - FDA
Roundup: September 17, 2024 |
| September 16, 2024 - FDA
Issues Draft Guidance on Conducting Multiregional Clinical Trials
in Oncology |
| September 13, 2024 - FDA
Roundup: September 13, 2024 |
| September 12, 2024 - FDA
Authorizes First Over-the-Counter Hearing Aid Software |
| September 11, 2024 - FDA
Issues Warning Letters to Two Chinese Firms Regarding Data Quality
and Integrity Concerns, Violative Lab Practices |
| September 10, 2024 - FDA
Roundup: September 10, 2024 |
| September 6, 2024 - FDA
Roundup: September 6, 2024 |
| September 5, 2024 - Youth
E-Cigarette Use Drops to Lowest Level in a Decade |
See the current
MedSun newsletter at the FDA website for Recalls and Safety Alerts,
Highlighted Reports, and Links to FDA/CDRH Databases and Other Information
Sources.
|
|
